These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Is psoriasis a dependent cardiovascular risk factor?]. Wakkee M; de Jong EM Ned Tijdschr Geneeskd; 2013; 157(11):A5417. PubMed ID: 23484510 [TBL] [Abstract][Full Text] [Related]
43. Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies. Driessen RJ; Boezeman JB; Van De Kerkhof PC; De Jong EM J Dermatolog Treat; 2009; 20(1):42-7. PubMed ID: 18649164 [TBL] [Abstract][Full Text] [Related]
44. Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors. Gisondi P; Girolomoni G Semin Thromb Hemost; 2009 Apr; 35(3):313-24. PubMed ID: 19452407 [TBL] [Abstract][Full Text] [Related]
46. Atheroma plaque, metabolic syndrome and inflammation in patients with psoriasis. Arias-Santiago S; Orgaz-Molina J; Castellote-Caballero L; Arrabal-Polo MÁ; García-Rodriguez S; Perandrés-López R; Ruiz JC; Naranjo-Sintes R; Zubiaur M; Sancho J; Buendía-Eisman A Eur J Dermatol; 2012; 22(3):337-44. PubMed ID: 22503884 [TBL] [Abstract][Full Text] [Related]
47. Psoriasis and cardiovascular disorders. Ryan C; Menter A G Ital Dermatol Venereol; 2012 Apr; 147(2):179-87. PubMed ID: 22481581 [TBL] [Abstract][Full Text] [Related]
48. [Cardiovascular risk profile of patients with psoriasis]. Di Lisi D; Macaione F; Corrado E; Bonura F; Novo G; Peritore A; Meschisi M; Cuttitta F; Bongiorno MR; Novo S Recenti Prog Med; 2013 Mar; 104(3):102-5. PubMed ID: 23548953 [TBL] [Abstract][Full Text] [Related]
49. [Comorbidities and psoriasis. Impact on clinical practice]. Gerdes S; Mrowietz U Hautarzt; 2012 Mar; 63(3):202-13. PubMed ID: 22373901 [TBL] [Abstract][Full Text] [Related]
50. Examining the risk of cardiovascular disease in patients with psoriasis: a critical review. Papp K; Poulin Y; Vieira A J Cutan Med Surg; 2013; 17(2):89-105. PubMed ID: 23582163 [TBL] [Abstract][Full Text] [Related]
51. [Psoriasis, a systemic disease?]. Puig-Sanz L Actas Dermosifiliogr; 2007; 98(6):396-402. PubMed ID: 17663929 [TBL] [Abstract][Full Text] [Related]
52. Psoriasis and Co-morbidity. Amin M; Lee EB; Tsai TF; Wu JJ Acta Derm Venereol; 2020 Jan; 100(3):adv00033. PubMed ID: 31971602 [TBL] [Abstract][Full Text] [Related]
53. Psoriasis and comorbid diseases: Epidemiology. Takeshita J; Grewal S; Langan SM; Mehta NN; Ogdie A; Van Voorhees AS; Gelfand JM J Am Acad Dermatol; 2017 Mar; 76(3):377-390. PubMed ID: 28212759 [TBL] [Abstract][Full Text] [Related]
54. [Comorbidity in connection with psoriasis is more than psoriatic arthritis]. Kvist-Hansen A; Kaiser H; Skov L; Hansen PR Ugeskr Laeger; 2018 Jan; 180(2):. PubMed ID: 29368688 [TBL] [Abstract][Full Text] [Related]
55. Prevalence of metabolic syndrome and cardiovascular changes in patients with chronic plaque psoriasis and their correlation with disease severity: A hospital-based cross-sectional study. Kothiwala SK; Khanna N; Tandon N; Naik N; Sharma VK; Sharma S; Sreenivas V Indian J Dermatol Venereol Leprol; 2016; 82(5):510-8. PubMed ID: 27297282 [TBL] [Abstract][Full Text] [Related]